Suchergebnisse - "Bloem, Lourens T"

PubPharm (28)

1

A Natural Language Processing Approach Towards Harmonized Communication of Uncertainties Identified During the European Medicine Authorization Process

enthalten in: Clinical pharmacology and therapeutics | 2024

von Verweij, S. | Haverhoek, V. | Bergman, E. | +2

2

Agreement about Availability of Alternative Treatments for Innovative Drugs Assessed by the EMA and HTA Organizations

enthalten in: Clinical pharmacology and therapeutics | 2024

von Madrid Paredes, J. | Versteeg, J. | Vreman, R. | +1

3

Pembrolizumab Plus Chemotherapy Per PD-L1 Stratum In Patients With Metastatic Non-Small Cell Lung Cancer : Real-World Effectiveness Versus Trial Efficacy

enthalten in: Clinical lung cancer | 2024

von Verschueren, M. | Peters, B. | Bloem, L. | +5

4

High cost oncology drugs without proof of added benefit are burdening health systems

enthalten in: BMJ (Clinical research ed.) | 2024

von Brinkhuis, F. | Goettsch, W. | Mantel-Teeuwisse, A. | +1

5

Added benefit and revenues of oncology drugs approved by the European Medicines Agency between 1995 and 2020 : retrospective cohort study

enthalten in: BMJ (Clinical research ed.) | 2024

von Brinkhuis, F. | Goettsch, W. | Mantel-Teeuwisse, A. | +1

6

A Natural Language Processing Approach Towards Harmonized Communication of Uncertainties Identified During the European Medicine Authorization Process

enthalten in: Clinical Pharmacology & Therapeutics | 2024

von Verweij, S. | Haverhoek, V. | Bergman, E. | +2

7

Durvalumab after chemoradiotherapy in patients with stage III non-small-cell lung cancer : real-world outcomes versus clinical trial results

enthalten in: Immunotherapy | 2023

von Verschueren, M. | Dijs, T. | Gulikers, J. | +8

8

Neonatal pain score after use of paracetamol : Is there a relationship with serum trough concentration at steady state in preterm and term neonates?

enthalten in: International journal of clinical pharmacology and therapeutics | 2023

von van den Berg, R. | Laarman, A. | Bloem, L. | +5

9

European Conditional Marketing Authorization in a Rapidly Evolving Treatment Landscape : A Comprehensive Study of Anticancer Medicinal Products in 2006-2020

enthalten in: Clinical pharmacology and therapeutics | 2023

von Bloem, L. | Schelhaas, J. | López-Anglada, L. | +3

10

European Conditional Marketing Authorization in a Rapidly Evolving Treatment Landscape : A Comprehensive Study of Anticancer Medicinal Products in 2006–2020

enthalten in: Clinical Pharmacology & Therapeutics | 2023

von Bloem, L. | Schelhaas, J. | López‐Anglada, L. | +3